Acceptability of a proposed new tuberculosis vaccine among people deprived of liberty in Brazil
Bampi, J. V. B.; Arcanjo, G. G. d. A.; Santos, K. M.; Ventura, M. S.; Clark, R. A.; Thomas, K. A.; White, R. G.; Croda, J.
Show abstract
BackgroundGlobally tuberculosis (TB) persists as a public health threat, with an unequal burden of disease among populations. Targeting disease control, new vaccine candidates for adults and adolescents are currently in the development pipeline. If available, these products can be directed in vaccination campaigns for vulnerable populations, such as people deprived of liberty (PDL). This study aims to assess acceptability towards a proposed new TB vaccine and factors associated with hesitancy in a carceral settings at eight prison units in Brazil. MethodsWe performed a cross-sectional study among PDL in six male and two female prison units within 6 Brazilian cities from April 2025 to October 2025. Eligible participants included adults (over 18 years old) who could provide consent. Through prison census, we randomly selected 130 individuals for initial evaluation with structured questionnaire about sociodemographic status, TB disease beliefs, willingness to receive a hypothetical new TB vaccine, sources of information trusted and select reasons that could make them not take a vaccine. We also requested that individuals rated affirmations regarding TB vaccines in the Likert scale. We compared participants characteristics and answers to vaccine questionnaire within prison gender and reported vaccine acceptance groups. ResultsOf the 945 individuals evaluated, 4 were excluded due to missing questionnaire results, with 941 included for main analysis. In total, 95.2% of individuals reported that they would take the TB vaccine if available for them, with 94.1% acceptance in male prisons and 98.7% in female prisons. Compared to females, male individuals reported more distrust in vaccine safety (28.9% vs 14.5%, p <0.001), more community coercion to vaccine uptake (15.4% vs 5.6%, p<0.001) and worse TB knowledge (44.6% vs 31.2%, p<0.001). Overall, among individuals that would not accept vaccination, 77.8% and 55.6% of them did not trust vaccine safety and efficacy, respectively, 60.0% did not trust healthcare workers and 20.0% reported community coercion. ConclusionWe found that acceptability of a new TB vaccine in Brazilian prisons was very high. Despite few differences in intent to vaccinate regarding gender, individuals that refused vaccination more often reported problems with vaccine and healthcare trust, as well as a significant proportion of them reported possible community coercion for vaccine uptake. Our findings suggest that a new TB vaccine would be well accepted among PDL.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- COVID-19 vaccine hesitancy and conspiracy beliefs in Togo: Findings from two cross-sectional surveys 94%
- Mapping the Existing Body of Knowledge on New and Repurposed TB Vaccine Implementation: A Scoping Review 94%
- Health care workers’ self-perceived infection risk and COVID-19 vaccine uptake: a mixed methods study 93%
Similar papers in this journal
- Predictors of COVID-19 Vaccine Acceptability Among Refugees and Other Migrant Populations: A Systematic Scoping Review 94%
- COVID-19 vaccine hesitancy and refusal and associated factors in an adult population in Saskatchewan, Canada: Evidence from predictive modelling 94%
- COVID-19 vaccine for people who live and work in prisons worldwide: A scoping review 93%
Similar papers in this journal
- Essential Workers’ COVID-19 Vaccine Hesitancy, Misinformation and Informational Needs in the Republic of North Macedonia 94%
- Estimating vaccine confidence levels among healthcare staff and students of a tertiary institution in South Africa 94%
- The role of incentives in deciding to receive the available COVID-19 vaccine 93%
Similar papers in this journal
- One-dose ChAdOx1 nCoV-19 Vaccine Effectiveness Against Symptomatic COVID-19 in a vulnerable community in Rio de Janeiro, Brazil: test-negative design study 93%
- Attitudes towards a mandatory COVID-19 vaccination in France for the general population or healthcare workers in May 2021 92%
- Bivalent BNT162b2mRNA original/Omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared to the monovalent COVID-19 booster 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.